Eastman Kodak

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Kodak reports mixed Q4 results, focuses on innovation for growth

Kodak showcased a resilient performance in Q4 and full year 2022, marked by revenue growth and gross profit improvements. The company's focus on innovation and strategic investments bodes well for future prospects.
While facing challenges such as revenue fluctuations and currency impacts, Kodak's compliance with financial covenants and emphasis on cost controls position it for sustained profitability and growth.

Eastman Kodak reports Q1 growth in revenues and profit

Eastman Kodak's Q1 2023 performance showed revenue decline adjusted for foreign exchange but a significant increase in gross profit and net income. The company's focus on core businesses, smart revenues, and efficiency improvements positions it for sustainable growth despite market challenges.

Eastman Kodak reports Q2 revenue decline but boosts profitability

Eastman Kodak's Q2 2023 performance showed mixed results with revenue decline but improved profitability and net income.
The company's strategic strengths include investments in innovation, key acquisitions, and prudent financial management.
Challenges persist in revenue decline and global uncertainties, but opportunities exist in leveraging innovation and strategic partnerships for growth.

Eastman Kodak reports improved Q3 performance amidst challenges

Eastman Kodak's Q3 2023 performance showed resilience amidst challenges, with improved financial metrics and a focus on long-term strategy execution. The company's commitment to innovation, growth initiatives, and customer support positions it well for future opportunities.

Eastman Kodak reports mixed Q4 results, focuses on growth initiatives

Eastman Kodak's Q4 2023 performance showed improvements in gross profit and operational EBITDA, despite a revenue decrease. The company's strategic investments in growth areas and commitment to innovation are key strengths.
Challenges include revenue decline and net income decrease, highlighting the need for operational efficiency enhancements. Opportunities lie in leveraging investments for revenue growth and exploring new market segments for expansion.
With a focus on profitability, cash flow generation, and strategic initiatives, Eastman Kodak aims to navigate challenges and capitalize on growth opportunities for sustainable success in the future.

Eastman Kodak reports Q1 resilience with focus on innovation

Eastman Kodak's Q1 2024 performance showed resilience in managing revenue decline while improving operational efficiency and profitability. The company's strategic investments in innovation, print technology, and automation position it for long-term growth. Challenges persist in revenue generation, but Kodak's commitment to innovation and profitability drives its pursuit of opportunities in chemicals, manufacturing, and customer-centric solutions.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Traders appear to be heading for the exits.

Why Kodak Stock Plummeted Today

It's a Kodak moment for investor insanity on Wall Street -- and the enormous run-up in Eastman Kodak's stock is yet another example of the current market frothiness.

Analysis: Kodak's 530% stock surge is dangerous speculation

Investors should be used to new financings being announced after major stock surges.

The Nasty Surprise From Eastman Kodak

Shares of Eastman Kodak Co. KODK, -28.05% were down 24% in afternoon trading Monday, putting them on track for a third straight double-digit percentage decline

Kodak's stock tumbles again, after disclosing investors have converted debt into nearly 30 million common shares

Eastman Kodak Co on Monday granted its executive chairman options for 1.75 million shares as the result of what a person familiar with the arrangement described as an "understanding" with its board that had previously neither been listed in his employment contract nor made public.

Eastman Kodak top executive got Trump deal windfall on an 'understanding'

Exclusive: Eastman Kodak top executive got Trump deal windfall on an 'understanding'

The venerable photography company is shifting to drug manufacturing in an effort to fight the pandemic. From Samsung and Slack to Taco Bell and Toyota, here are some of the most dramatic business reinventions.

Film To Pharma: Kodak’s New Moment And Other Game-Changing Corporate Pivots

Eastman Kodak Company (NYSE: KODK) shares are trading lower on profit-taking after the stock rallied earlier this week following news the company received a government loan to manufacture drugs to treat a variety of conditions.

Why Kodak's Stock Is Trading Lower Today

The troubled camera company sold its pharmaceutical subsidiary for $4.6 billion in 1994 but now wants to return to the sector. Will it succeed?

Is Eastman Kodak Stock a Buy?

General Electric

The Nasdaq still managed to outpace the rest of the market.

Stock Markets Mostly Lower as GE Nears 30-Year Lows, Kodak's Winning Streak Ends

Options volume in Kodak is out of this world, but the biggest bets are pointing to a huge drop for the stock.

Kodak options are exploding, but traders are betting the bottom is about to fall out

Eastman Kodak Company (NYSE: KODK) shares gained another 19% in early Thursday trading and are now up a whopping 1,780% since last Friday’s close.

Kodak Short Sellers Are Getting Obliterated

TAIPEI, Taiwan--(BUSINESS WIRE)--Crest View International reports on Kodak shares surging 1,481% after Trump offers the company a lifeline to produce ingredients for virus drugs.

Crest View International Reports On Kodak Shares Soaring Almost 1,500% on Virus Drug Loan Deal

The net worth of Kodak’s top executive has skyrocketed on the company’s transformation from an ailing camera maker to cutting-edge pharmaceutical start-up — thanks in part to some timely share purchases. James Continenza, Kodak’s executive chairman and de facto CEO, was sitting pretty as the company’s largest individual shareholder — with 650,000 shares  — when.

Kodak’s top exec sees $200 million windfall on stock frenzy

Eastman Kodak shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
The post Stocks With Rising Relative Price Strength: Eastman Kodak appeared first on Investor's Business Daily.

Stocks With Rising Relative Price Strength: Eastman Kodak

Eastman Kodak Co CEO Jim Continenza added $79 million to his net worth on Wednesday when his options in the imaging company turned from worthless to lucrative thanks to a U.S. government loan for a pharmaceutical ingredients supply deal that super-charged the value of his shares.

Kodak CEO's fortune swells $79 million as stocks rally on U.S. government loan

The enormous rally in Kodak shares has no end in sight, after the Trump administration announced the company will be transformed into a pharmaceutical producer under the Defense Production Act.

Kodak's stock rose so fast it tripped 20 circuit breakers in a single day

Shares of iconic camera maker Eastman Kodak (NASDAQ: KODK) skyrocketed higher Wednesday by more than 400% in reaction to a pharmaceutical deal with the U.S. government.

In his own words: Kodak CEO explains pharma deal

Eastman Kodak saw heavy trading volume on Monday, prior to the company's announcement that it would manufacture drugs to help fight Covid-19.

Kodak executive chairman addresses jump in trading activity before government deal was announced

Eastman Kodak stock has tripled today alone after the company said it received a loan from the government to produce

Kodak Stock Skyrockets After Deal to Make Drug Ingredients

Kodak shares increased three-fold on Tuesday, and the stock is up over 1,450% approximately this week.

Kodak Stock Price Up Over 1,440% In Two Days

If there has been a story of riches to rags over time, Eastman Kodak Co. (NYSE: KODK) might get to be the face of that story.

Will Eastman Kodak’s Tarnished Past Haunt Its New Future?

Kodak continued to soar after the Trump administration announced a deal for production of generic drug ingredients to help fight coronavirus.
The post Kodak Stock Resumes Trading After 650% Jump On Trump Drug Deal appeared first on Investor's Business Daily.

Kodak Stock Resumes Trading After 650% Jump On Trump Drug Deal

President Trump touted the company's new coronavirus-related pharmaceutical ambitions.

Why Kodak Stock Is Soaring More Than 500% Today

The camera giant has been awarded a huge government loan aimed at reducing U.S. reliance on foreign pharmaceutical supply.

News for Eastman Kodak Stock (KODK)